Clinical Trials Logo

Stenotrophomonas Infection clinical trials

View clinical trials related to Stenotrophomonas Infection.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03506191 Active, not recruiting - Critical Illness Clinical Trials

Pneumonia Due to Stenotrophomonas Maltophilia in ICUs

RETROSTENO
Start date: January 1, 2017
Phase:
Study type: Observational

Pneumonia is a major cause of ICU admission, or may complicate ICU course. Among the causative pathogens, Stenotrophomonas Maltophilia is a rare pathogen, but affects usually patients with chronic pulmonary co-morbidities, or with long duration of mechanical ventilation and multiples treatment with broad spectrum antimicrobial therapy. However, there are only a paucity of data regarding epidemiology, impact and outcome of Pneumonia due to Stenotrophomonas Maltophilia in critically ill patients. Primary objective was to study factors associated with mortality in case of Pneumonia due to Stenotrophomonas Maltophilia. Secondary objectives were to describe factors associated with morbidity of Pneumonia due to Stenotrophomonas Maltophilia (duration of mechanical ventilation, ICU length of stay), and to report the characteristics of critically ill patients presenting Pneumonia due to Stenotrophomonas Maltophilia.